Skip to main content
Bluvy Tube
Press Esc to exit fullscreen
Volume m
/
i
Theater mode t
f
/
Ashwagandha Market in Crisis: Leaf vs. Root Standards Threaten $1.5B Industry #AshwagandhaCrisis #SupplementRegulations #DietarySupplements

Keyboard shortcuts

Space K
Play / pause
← →
Back / forward 5 s
J L
Back / forward 10 s
0–9
Jump to 0%–90% of the video
Home End
Start / end
, .
Previous / next frame (while paused)
< >
Slower / faster
↑ ↓
Volume
M
Mute / unmute
C
Captions
F
Fullscreen
I
Picture-in-picture
T
Theater mode
?
Show this help

Ashwagandha Market in Crisis: Leaf vs. Root Standards Threaten $1.5B Industry #AshwagandhaCrisis #SupplementRegulations #DietarySupplements

@nutrimarkets.bsky.social

Subscribe
0 views Published on 24/09/2026 01:17
#dietarysupplements #supplementregulations #ashwagandhacrisis
Ashwagandha Market in Crisis: Leaf vs. Root Standards Threaten $1.5B Industry #AshwagandhaCrisis #SupplementRegulations #DietarySupplements
1 comment
?
@ryzolabs.bsky.social · 25/09/2026 10:20
Clinical trials heavily favor root-only extracts for safety and efficacy, as leaves contain higher levels of the cytotoxic compound withaferin A.
https://blog.ryzolabs.shop/2026/07/ashwagandha-ashwagandha-root-extract.html?utm_source=bluesky&utm_medium=social&utm_campaign=ryzo_bluesky
View original post on Bluesky
Link copied to clipboard

Sign in

Time to take a break

You've been watching videos for 30 minutes straight: give yourself 5 minutes away from the screen. Stand up, stretch, grab a glass of water… Your videos will be right here when you're back.